In tendinopathy, HIF-1 is upregulated, which in turn activates its target genes and modulates the elevated expression of pro-inflammatory cytokines, apoptotic factors, and angiogenesis, exacerbating the condition [7,16,17,18]. The gene discussed is HIF1A; the disease is disease of the tendon.